Fangyan Gao

647 total citations · 1 hit paper
13 papers, 381 citations indexed

About

Fangyan Gao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fangyan Gao has authored 13 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Fangyan Gao's work include Cancer Cells and Metastasis (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fangyan Gao is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fangyan Gao collaborates with scholars based in China. Fangyan Gao's co-authors include Xiaoxiang Guan, Runtian Wang, Kun Xu, Xintong Li, Jinyi Huang, Chengjun Zhu, Cenzhu Wang, Guohua Zhou, Hui Xie and Yongqian Shu and has published in prestigious journals such as Journal of the American Chemical Society, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and BMC Cancer.

In The Last Decade

Fangyan Gao

12 papers receiving 378 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer

2023 83 citations Xintong Li, Fangyan Gao et al. Journal of the American Chemical Society profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fangyan Gao China	9	253	165	92	70	59	13	381
Xiaohua Jie China	12	300 1.2×	168 1.0×	110 1.2×	64 0.9×	128 2.2×	17	474
Huiling Zhou China	12	292 1.2×	86 0.5×	99 1.1×	53 0.8×	43 0.7×	22	375
Shu Lin China	8	238 0.9×	159 1.0×	102 1.1×	33 0.5×	26 0.4×	16	372
Mary R. Doherty United States	5	262 1.0×	318 1.9×	151 1.6×	40 0.6×	95 1.6×	7	500
Shoujie Chai China	10	239 0.9×	204 1.2×	143 1.6×	109 1.6×	42 0.7×	12	431
Mushtaq Ahmad Nengroo India	10	181 0.7×	87 0.5×	78 0.8×	81 1.2×	40 0.7×	15	308
Hongchao Tang China	10	171 0.7×	102 0.6×	107 1.2×	49 0.7×	55 0.9×	25	288
Jianhua Xu China	8	180 0.7×	86 0.5×	107 1.2×	43 0.6×	60 1.0×	13	302
Gargi Maity United States	12	243 1.0×	127 0.8×	147 1.6×	22 0.3×	67 1.1×	24	412
Florence Giffard France	13	320 1.3×	90 0.5×	173 1.9×	54 0.8×	43 0.7×	23	454

Countries citing papers authored by Fangyan Gao

Since Specialization

Citations

This map shows the geographic impact of Fangyan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyan Gao more than expected).

Fields of papers citing papers by Fangyan Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyan Gao. The network helps show where Fangyan Gao may publish in the future.

Co-authorship network of co-authors of Fangyan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyan Gao. A scholar is included among the top collaborators of Fangyan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyan Gao. Fangyan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zhao, Yuhan, et al.. (2025). AR/ERK co-targeting triggers ferroptosis via FOXC2 in triple-negative breast cancer. Science China Life Sciences. 69(1). 85–100.

Gao, Fangyan, et al.. (2024). Cell-cell communication characteristics in breast cancer metastasis. Cell Communication and Signaling. 22(1). 55–55. 12 indexed citations

Gao, Fangyan, Runtian Wang, Lingling Fan, et al.. (2024). Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer. Acta Pharmaceutica Sinica B. 14(6). 2685–2697. 19 indexed citations

Gao, Fangyan, et al.. (2023). c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Communication and Signaling. 21(1). 28–28. 90 indexed citations

Wang, Runtian, Gaigai Li, Fangyan Gao, et al.. (2023). Ultrasound-responsive spherical nucleic acid against c-Myc/PD-L1 to enhance anti-tumoral macrophages in triple-negative breast cancer progression. Science China Life Sciences. 67(4). 698–710. 5 indexed citations

Li, Xintong, Fangyan Gao, Yuxuan Ma, et al.. (2023). c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer. Journal of the American Chemical Society. 145(16). 9334–9342. 83 indexed citations breakdown →

Wang, Runtian, Qin Chen, Xintong Li, et al.. (2022). Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes. Acta Biochimica et Biophysica Sinica. 54(9). 1336–1348. 6 indexed citations

Li, Xintong, Lin Tang, Qin Chen, et al.. (2022). Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer. Chinese Medical Journal. 135(20). 2436–2445. 10 indexed citations

Wang, Runtian, Kun Xu, Fangyan Gao, Jinyi Huang, & Xiaoxiang Guan. (2021). Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188590–188590. 24 indexed citations

10.

Wang, Qianqian, Wen Gao, Fangyan Gao, et al.. (2021). Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting. BMC Cancer. 21(1). 602–602. 9 indexed citations

11.

Xu, Kun, Runtian Wang, Hui Xie, et al.. (2021). Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis. Oncogenesis. 10(10). 66–66. 94 indexed citations

12.

Gao, Fangyan, Qianqian Wang, Chang Zhang, et al.. (2021). RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 25(5). 2418–2425. 21 indexed citations

13.

Zhang, Chen, et al.. (2020). Checkpoint inhibitor pneumonitis in Chinese lung cancer patients: clinical characteristics and risk factors. Annals of Palliative Medicine. 9(6). 3957–3965. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact